Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07644052
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use DisorderPleoPharma, Inc.RecruitingPhase 3
NCT07644052Recruiting
Phase 3
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cann...PleoPharma, Inc.
NCT07645495
Frequency Rhythmic Electrical Modulated Stimulation Therapy in Chronic Ulcers.Beni-Suef UniversityNot Yet RecruitingNot Applicable
NCT07645495Not Yet Recruiting
Not Applicable
Frequency Rhythmic Electrical Modulated Stimulation Therapy in Chronic Ulcers.Beni-Suef University
NCT07646223
Vancomycin Efficacy in Response to Dysbiosis in Atypical ColitisFimlab laboratoriesNot Yet RecruitingPhase 2
NCT07646223Not Yet Recruiting
Phase 2
Vancomycin Efficacy in Response to Dysbiosis in Atypical ColitisFimlab laboratories
NCT07645391
Targeted Early Detection Program in Men at High Genetic Risk for Prostate CancerNational Cancer Institute (NCI)Recruiting
NCT07645391Recruiting
—
Targeted Early Detection Program in Men at High Genetic Risk for Prostate CancerNational Cancer Institute...
NCT07645781
Cervical Stabilization Exercises IN Subacromial Impingement SyndromeCairo UniversityNot Yet RecruitingNot Applicable
NCT07645781Not Yet Recruiting
Not Applicable
Cervical Stabilization Exercises IN Subacromial Impingement SyndromeCairo University
NCT07645066
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients With Sinus Node DysfunctionShanghai Tong Ren HospitalNot Yet RecruitingNot Applicable
NCT07645066Not Yet Recruiting
Not Applicable
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients...Shanghai Tong Ren Hospita...
NCT07644299
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Concept StudyCiusss de L'Est de l'Île de MontréalNot Yet RecruitingNot Applicable
NCT07644299Not Yet Recruiting
Not Applicable
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Co...Ciusss de L'Est de l'Île...
NCT07643831
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2- Early or Locally Advanced/Metastatic Breast CancerGenentech, Inc.Unknown
NCT07643831Unknown
—
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2-...Genentech, Inc.
NCT07645768
Is Anterior Reversed Proximal Humeral Locking Plate System (PHILOS) a Safe Alternative to Conventional Posterior Double Plating in Extra-Articular Distal Shaft Humeral FracturesCairo UniversityActive Not RecruitingNot Applicable
NCT07645768Active Not Recruiting
Not Applicable
Is Anterior Reversed Proximal Humeral Locking Plate System (PHILOS) a Safe Alter...Cairo University
NCT07646262
Gluten-Free vs Mediterranean Diet in Rheumatoid ArthritisHasan Kalyoncu UniversityRecruitingNot Applicable
NCT07646262Recruiting
Not Applicable
Gluten-Free vs Mediterranean Diet in Rheumatoid ArthritisHasan Kalyoncu University
NCT07643935
Prognostic Value of 177Lutetium-PSMA Single Photon Emission Tomography and Timing of ResponseCentral Hospital, Nancy, FranceNot Yet Recruiting
NCT07643935Not Yet Recruiting
—
Prognostic Value of 177Lutetium-PSMA Single Photon Emission Tomography and Timin...Central Hospital, Nancy,...
NCT07644312
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPGNationwide Children's HospitalNot Yet RecruitingPhase 2
NCT07644312Not Yet Recruiting
Phase 2
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG...Nationwide Children's Hos...
NCT07645248
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)GlaxoSmithKlineNot Yet RecruitingPhase 3
NCT07645248Not Yet Recruiting
Phase 3
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1...GlaxoSmithKline
NCT07646548
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsRegeneron PharmaceuticalsNot Yet RecruitingPhase 1
NCT07646548Not Yet Recruiting
Phase 1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Be...Regeneron Pharmaceuticals
NCT07646080
Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma ProtuberansYanjie Zhang, MDNot Yet RecruitingPhase 2
NCT07646080Not Yet Recruiting
Phase 2
Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemothera...Yanjie Zhang, MD
NCT07644143
Effect of A Theory-based Multicomponent eHealth Intervention ProgramTaipei Medical UniversityNot Yet RecruitingNot Applicable
NCT07644143Not Yet Recruiting
Not Applicable
Effect of A Theory-based Multicomponent eHealth Intervention ProgramTaipei Medical University
NCT07645157
Sertraline Combined With Multi-Strain Probiotics for Adolescent DepressionFirst Affiliated Hospital of Chongqing Medical UniversityRecruitingPhase 2
NCT07645157Recruiting
Phase 2
Sertraline Combined With Multi-Strain Probiotics for Adolescent DepressionFirst Affiliated Hospital...
NCT07645404
The Effect of Mental Fatigue on Upper Extremity Functional PerformanceIzmir Bakircay UniversityNot Yet RecruitingNot Applicable
NCT07645404Not Yet Recruiting
Not Applicable
The Effect of Mental Fatigue on Upper Extremity Functional PerformanceIzmir Bakircay University
NCT07646418
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International UniversityRecruitingNot Applicable
NCT07646418Recruiting
Not Applicable
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International Univ...
Result Breakdown
Not yet recruiting13 (65%)
Recruiting5 (25%)
Unknown1 (5%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 24 (20%)
Phase 32 (10%)
Phase 11 (5%)